Sugammadex Sodium

• Category Reversal Neuromuscular Blockade
• CAS 343306-79-6
• Specification In-house
• US DMF N/A
• CEP / Other DMF N/A
• GMP certification TFDA
• Inspection TFDA
• StatusCompleted process development
• Major Market EU, Turkey, Japan